Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies

Background: Patients with hematological malignancies (HM), including multiple myeloma (MM), frequently suffer from immune deficiency-associated infectious complications because of both the disease and the treatment. Alarming results from China and the UK confirm the vulnerability of HM patients to s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Diagnostics (Basel)
Prif Awduron: Mahimainathan, Lenin, Narasimhan, Madhusudhanan, Corchado, Rolando, Patel, Hetalkumari, Kansagra, Ankit, Devaraj, Sridevi, Geethakumari, Praveen Ramakrishnan, Muthukumar, Alagarraju
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2020
Pynciau:
Communication
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7760559/
https://ncbi.nlm.nih.gov/pubmed/33255154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10120992
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg